NDC 50090-2445

XIFAXAN

Rifaximin

XIFAXAN is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by A-s Medication Solutions. The primary component is Rifaximin.

Product ID50090-2445_3b963540-95c2-46ef-9d65-f9e62652daff
NDC50090-2445
Product TypeHuman Prescription Drug
Proprietary NameXIFAXAN
Generic NameRifaximin
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2004-07-25
Marketing CategoryNDA /
Application NumberNDA021361
Labeler NameA-S Medication Solutions
Substance NameRIFAXIMIN
Active Ingredient Strength200 mg/1
Pharm ClassesRifamycin Antibacterial [EPC],Rifamycins [CS]
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 50090-2445-0

9 TABLET in 1 BOTTLE (50090-2445-0)
Marketing Start Date2016-08-08
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 50090-2445-0 [50090244500]

XIFAXAN TABLET
Marketing CategoryNDA
Application NumberNDA021361
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2018-02-06
Marketing End Date2018-02-06

Drug Details

NDC Crossover Matching brand name "XIFAXAN" or generic name "Rifaximin"

NDCBrand NameGeneric Name
50090-2445XIFAXANrifaximin
55154-6777XIFAXANrifaximin
65649-301XIFAXANrifaximin
65649-303XIFAXANrifaximin
68151-4980XIFAXANrifaximin
68258-1107XIFAXANRIFAXIMIN
69189-0309XIFAXANrifaximin

Trademark Results [XIFAXAN]

Mark Image

Registration | Serial
Company
Trademark
Application Date
XIFAXAN
XIFAXAN
78428755 2965332 Live/Registered
ALFASIGMA S.P.A.
2004-06-02

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.